152 related articles for article (PubMed ID: 30600292)
1. Gene Therapy for Treatment of Chronic Hyperammonemia in a Rat Model of Hepatic Encephalopathy.
Espíritu-Ramírez P; Ortega-Balderas NY; Sevilla-Tapia L; Montiel-Martínez AG; Pastor-Flores AR; Palomares LA; Torres-Vega MA
Ann Hepatol; 2018 Oct; 17(6):1026-1034. PubMed ID: 30600292
[TBL] [Abstract][Full Text] [Related]
2. Delivery of glutamine synthetase gene by baculovirus vectors: a proof of concept for the treatment of acute hyperammonemia.
Torres-Vega MA; Vargas-Jerónimo RY; Montiel-Martínez AG; Muñoz-Fuentes RM; Zamorano-Carrillo A; Pastor AR; Palomares LA
Gene Ther; 2015 Jan; 22(1):58-64. PubMed ID: 25338921
[TBL] [Abstract][Full Text] [Related]
3. Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats.
Jover-Cobos M; Noiret L; Lee K; Sharma V; Habtesion A; Romero-Gomez M; Davies N; Jalan R
J Hepatol; 2014 Mar; 60(3):545-53. PubMed ID: 24512823
[TBL] [Abstract][Full Text] [Related]
4. Hepatic glutamine synthetase augmentation enhances ammonia detoxification.
Soria LR; Nitzahn M; De Angelis A; Khoja S; Attanasio S; Annunziata P; Palmer DJ; Ng P; Lipshutz GS; Brunetti-Pierri N
J Inherit Metab Dis; 2019 Nov; 42(6):1128-1135. PubMed ID: 30724386
[TBL] [Abstract][Full Text] [Related]
5. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.
Jover R; Rodrigo R; Felipo V; Insausti R; Sáez-Valero J; García-Ayllón MS; Suárez I; Candela A; Compañ A; Esteban A; Cauli O; Ausó E; Rodríguez E; Gutiérrez A; Girona E; Erceg S; Berbel P; Pérez-Mateo M
Hepatology; 2006 Jun; 43(6):1257-66. PubMed ID: 16729306
[TBL] [Abstract][Full Text] [Related]
6. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy.
Rodrigo R; Cauli O; Gomez-Pinedo U; Agusti A; Hernandez-Rabaza V; Garcia-Verdugo JM; Felipo V
Gastroenterology; 2010 Aug; 139(2):675-84. PubMed ID: 20303348
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy.
Brusilow SW; Koehler RC; Traystman RJ; Cooper AJ
Neurotherapeutics; 2010 Oct; 7(4):452-70. PubMed ID: 20880508
[TBL] [Abstract][Full Text] [Related]
8. Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase.
Qvartskhava N; Lang PA; Görg B; Pozdeev VI; Ortiz MP; Lang KS; Bidmon HJ; Lang E; Leibrock CB; Herebian D; Bode JG; Lang F; Häussinger D
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5521-6. PubMed ID: 25870278
[TBL] [Abstract][Full Text] [Related]
9. Sex is associated with differences in oxidative stress and susceptibility to severe hepatic encephalopathy in bile-duct ligated rats.
Macedo de Oliveira M; Monnet-Aimard A; Bosoi CR; Tremblay M; Rose CF
J Neurochem; 2022 Aug; 162(4):337-351. PubMed ID: 35771118
[TBL] [Abstract][Full Text] [Related]
10. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
Kristiansen RG
Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377
[TBL] [Abstract][Full Text] [Related]
11. Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
Hadjihambi A; De Chiara F; Hosford PS; Habtetion A; Karagiannis A; Davies N; Gourine AV; Jalan R
Hepatology; 2017 Apr; 65(4):1306-1318. PubMed ID: 28066916
[TBL] [Abstract][Full Text] [Related]
12. Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase.
Cooper AJ
Metab Brain Dis; 2013 Jun; 28(2):119-25. PubMed ID: 23065027
[TBL] [Abstract][Full Text] [Related]
13. Glutamine synthetase in brain: effect of ammonia.
Suárez I; Bodega G; Fernández B
Neurochem Int; 2002; 41(2-3):123-42. PubMed ID: 12020613
[TBL] [Abstract][Full Text] [Related]
14. Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia.
Bak LK; Iversen P; Sørensen M; Keiding S; Vilstrup H; Ott P; Waagepetersen HS; Schousboe A
Metab Brain Dis; 2009 Mar; 24(1):135-45. PubMed ID: 19067142
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered E. coli Nissle attenuates hyperammonemia and prevents memory impairment in bile-duct ligated rats.
Ochoa-Sanchez R; Oliveira MM; Tremblay M; Petrazzo G; Pant A; Bosoi CR; Perreault M; Querbes W; Kurtz CB; Rose CF
Liver Int; 2021 May; 41(5):1020-1032. PubMed ID: 33548108
[TBL] [Abstract][Full Text] [Related]
16. Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats.
Fries AW; Dadsetan S; Keiding S; Bak LK; Schousboe A; Waagepetersen HS; Simonsen M; Ott P; Vilstrup H; Sørensen M
J Cereb Blood Flow Metab; 2014 Mar; 34(3):460-6. PubMed ID: 24346692
[TBL] [Abstract][Full Text] [Related]
17. Hepatic encephalopathy is linked to alterations of autophagic flux in astrocytes.
Lu K; Zimmermann M; Görg B; Bidmon HJ; Biermann B; Klöcker N; Häussinger D; Reichert AS
EBioMedicine; 2019 Oct; 48():539-553. PubMed ID: 31648987
[TBL] [Abstract][Full Text] [Related]
18. Bile duct ligation plus hyperammonemia in rats reproduces the alterations in the modulation of soluble guanylate cyclase by nitric oxide in brain of cirrhotic patients.
Rodrigo R; Jover R; Candela A; Compañ A; Sáez-Valero J; Erceg S; Felipo V
Neuroscience; 2005; 130(2):435-43. PubMed ID: 15664700
[TBL] [Abstract][Full Text] [Related]
19. DNA-Encoded Glutamine Synthetase Enzyme as Ammonia-Lowering Therapeutic for Hyperammonemia.
Khoshnejad M; Dia Y; Patel A; Xu Z; Zhu X; Yun K; Wojtak K; Qureshi R; Humeau L; Muthumani K; Weiner DB
Nucleic Acid Ther; 2020 Dec; 30(6):379-391. PubMed ID: 32907467
[TBL] [Abstract][Full Text] [Related]
20. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.
Tapper EB; Jiang ZG; Patwardhan VR
Mayo Clin Proc; 2015 May; 90(5):646-58. PubMed ID: 25865476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
